Dr. Alex Tatem @DrAlexTatem · 01 Sep 2026
Peter Attia went after peptides. So I went through his argument point by point. BPC-157. CJC-1295. Human evidence. Safety data. FDA regulation. The patent problem. And the difference between “we need more research” and “this doesn’t work.” Peter’s a smart guy—but I think he’s https://t.co/izYGVeW4LB
41 583Views
266Likes
23Reposts
40Replies
10Quotes
170Bookmarks
Is that a lot?
1.11×vs this author's median37 588 views is typical
50Percentile for this authorof 6 recent posts
12.3×vs 10K–100K median3 383 views is typical
2.4× audienceReachviews ÷ followers
0.81%Engagement rateof viewers reacted